{"filing":{"accession_number":"0001576280-26-000036","cik":"0001576280","ticker":"GH","company_name":"Guardant Health, Inc.","form":"8-K","filing_date":"2026-07-30","report_date":"2026-07-30","primary_document":"gh-20260730.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1576280/000157628026000036/gh-20260730.htm"},"events":[{"id":22662,"run_id":20501,"accession_number":"0001576280-26-000036","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Guardant Health issued a press release on July 30, 2026 announcing financial results for the fiscal quarter ended June 30, 2026, disclosing Q2 2026 revenue of $335.0 million (44% growth), net loss of $120.1 million, and raising full-year 2026 revenue guidance to $1.34–$1.36 billion (36–38% growth). This is a standard quarterly earnings release with detailed financial statements and forward guidance, materially affecting investor assessment of the company's financial performance and outlook.","company_name":"Guardant Health, Inc.","ticker":"GH","filing_date":"2026-07-30","form":"8-K","submitted_at":null,"items":[{"id":22661,"accession_number":"0001576280-26-000036","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Guardant Health issued a press release on July 30, 2026 announcing financial results for the fiscal quarter ended June 30, 2026, disclosing Q2 2026 revenue of $335.0 million (44% growth), net loss of $120.1 million, and raising full-year 2026 revenue guidance to $1.34–$1.36 billion (36–38% growth). This is a standard quarterly earnings release with detailed financial statements and forward guidance, materially affecting investor assessment of the company's financial performance and outlook.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-02T02:15:09.970151+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":22661,"accession_number":"0001576280-26-000036","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Guardant Health issued a press release on July 30, 2026 announcing financial results for the fiscal quarter ended June 30, 2026, disclosing Q2 2026 revenue of $335.0 million (44% growth), net loss of $120.1 million, and raising full-year 2026 revenue guidance to $1.34–$1.36 billion (36–38% growth). This is a standard quarterly earnings release with detailed financial statements and forward guidance, materially affecting investor assessment of the company's financial performance and outlook.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-02T02:15:09.970151+00:00","company_name":"Guardant Health, Inc.","ticker":"GH","filing_date":"2026-07-30"}]}